GCIA
ETNB

Gabelli & Co Investment Advisers’s 89bio ETNB Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-417,850
Closed -$6.14M – 290
2025
Q3 		$6.14M Buy
+417,850
New +$4.26M 0.98% 26

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's ETNB Position: Q4 2025 in Review

Gabelli & Co Investment Advisers sold out of 89bio (ETNB) in Q4 2025, closing a stake of 417,850 shares — an estimated $6.14M sold.

Gabelli & Co Investment Advisers first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $6.14M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Gabelli & Co Investment Advisers reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 417,850 89bio shares in Q4 2025, an estimated $6.14M.
  • Gabelli & Co Investment Advisers first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's 89bio position peaked at $6.14M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2025, filed 5 Feb 2026.